↓ Skip to main content

Cochrane Database of Systematic Reviews

Sulpiride versus placebo for schizophrenia

Overview of attention for article published in this source, April 2009
Altmetric Badge

Mentioned by

12 X users
1 Wikipedia page


19 Dimensions

Readers on

33 Mendeley
Sulpiride versus placebo for schizophrenia
Published by
John Wiley & Sons, Ltd, April 2009
DOI 10.1002/14651858.cd007811
Pubmed ID

Omori, Ichiro M, Wang, Jijun


Sulpiride is a relatively old antipsychotic drug reputed to have low incidence of adverse effects and an effect on the negative symptoms of schizophrenia. This relatively inexpensive antipsychotic drug has a similar neuropharmacological profile to several novel atypical drugs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 32 97%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 6 18%
Student > Ph. D. Student 5 15%
Researcher 4 12%
Student > Postgraduate 3 9%
Student > Bachelor 2 6%
Other 6 18%
Unknown 7 21%
Readers by discipline Count As %
Medicine and Dentistry 11 33%
Psychology 7 21%
Social Sciences 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 1 3%
Other 1 3%
Unknown 8 24%